WO2012144754A3 - Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof - Google Patents

Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof Download PDF

Info

Publication number
WO2012144754A3
WO2012144754A3 PCT/KR2012/002450 KR2012002450W WO2012144754A3 WO 2012144754 A3 WO2012144754 A3 WO 2012144754A3 KR 2012002450 W KR2012002450 W KR 2012002450W WO 2012144754 A3 WO2012144754 A3 WO 2012144754A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibitory effects
isolated therefrom
compound isolated
active ingredient
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/002450
Other languages
French (fr)
Korean (ko)
Other versions
WO2012144754A2 (en
Inventor
박현
김경민
송현옥
김성연
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Academic Cooperation Foundation of Wonkwang University
Original Assignee
Industry Academic Cooperation Foundation of Wonkwang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry Academic Cooperation Foundation of Wonkwang University filed Critical Industry Academic Cooperation Foundation of Wonkwang University
Publication of WO2012144754A2 publication Critical patent/WO2012144754A2/en
Publication of WO2012144754A3 publication Critical patent/WO2012144754A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

The invention relates to a Galla Rhois extract having inhibitory effects, or to a compound isolated therefrom, which has superior antiviral effects against diseases caused by new influenza viruses, the avian influenza virus, and the coronavirus which is infectious to the human body or commonly infectious to humans and animals, and can thus be used for pharmaceutical compositions, functional health foods, feed additives, or feeds.
PCT/KR2012/002450 2011-04-19 2012-04-02 Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof Ceased WO2012144754A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110036241A KR101317318B1 (en) 2011-04-19 2011-04-19 A composition comprising the extract of Galla Rhois or the compounds isolated therefrom showing inhibiting activity of novel influenza, avian influenza, or SARS syndrome
KR10-2011-0036241 2011-04-19

Publications (2)

Publication Number Publication Date
WO2012144754A2 WO2012144754A2 (en) 2012-10-26
WO2012144754A3 true WO2012144754A3 (en) 2013-01-10

Family

ID=47042016

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/002450 Ceased WO2012144754A2 (en) 2011-04-19 2012-04-02 Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof

Country Status (2)

Country Link
KR (1) KR101317318B1 (en)
WO (1) WO2012144754A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11154531B2 (en) * 2020-02-08 2021-10-26 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
US20210236580A1 (en) * 2020-04-07 2021-08-05 Sytheon Ltd Methods and Compositions for Mitigating Symptoms of Acute Respiratory Distress Syndrome
AU2021260663A1 (en) * 2020-04-23 2022-11-10 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
KR102456749B1 (en) 2020-04-28 2022-10-21 서울대학교산학협력단 Composition for preventing or treating swine influenza virus disease comprising Curcuma longa extract or sesquiterpenoids isolated therefrom as active ingredients
CN111658631A (en) * 2020-06-11 2020-09-15 广东盛普生命科技有限公司 Application of gallic acid and its derivatives and structural analogs in preparing anti-coronavirus medicine
CN111574571A (en) * 2020-06-11 2020-08-25 石河子大学 Separation method and application of effective part of gallnut
US20240041854A1 (en) * 2020-07-30 2024-02-08 Otsuka Pharmaceutical Factory, Inc. Cold medicine and antiviral medicine
CN112521432B (en) * 2020-11-25 2022-05-06 深圳市三启药物开发有限公司 Star-shaped spine protein targeted bifunctional compound for resisting respiratory tract infection virus and preparation method and application of salts thereof
KR102665503B1 (en) * 2021-04-15 2024-05-17 에이피알지 주식회사 Composition for the prevention or treatment of SARS-CoV-2 infection, comprising the extract of Galla rhois as an active ingredient
WO2023038480A1 (en) * 2021-09-08 2023-03-16 에이피알지 주식회사 Composition, for preventing, treating or relieving influenza virus infection, comprising mixture of agrimonia pilosa extract and galla rhois extract as active ingredient
KR102420201B1 (en) 2022-01-17 2022-07-13 주식회사 유이케미칼 Eco-friendly quarantine composition with virus killing function with phospholipid envelope
KR102679048B1 (en) * 2022-04-18 2024-07-01 (주)유제이 Harmful birds repellent composition
KR20240045546A (en) 2022-09-30 2024-04-08 (주)예스킨 Anti-influenza viral agent

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01172330A (en) * 1987-12-26 1989-07-07 Nisshin Flour Milling Co Ltd Preventive and remedy for infectious disease of salmonella typhimurium of mammals and birds
JPH0625003A (en) * 1992-04-27 1994-02-01 Showa Shell Sekiyu Kk Galenical drug-containing antiviral agent
KR20080084477A (en) * 2007-03-16 2008-09-19 원광대학교산학협력단 Compositions containing gall and bark extract with antimicrobial and antiviral activity
KR20090072527A (en) * 2007-12-28 2009-07-02 삼광생명과학 주식회사 A composition containing a gall bladder extract having an antimicrobial activity or a compound separated therefrom as an active ingredient
KR20090072526A (en) * 2007-12-28 2009-07-02 삼광생명과학 주식회사 Veterinary composition containing as an active ingredient, gall extract or antibacterial activity with antibacterial and antiviral activity

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01172330A (en) * 1987-12-26 1989-07-07 Nisshin Flour Milling Co Ltd Preventive and remedy for infectious disease of salmonella typhimurium of mammals and birds
JPH0625003A (en) * 1992-04-27 1994-02-01 Showa Shell Sekiyu Kk Galenical drug-containing antiviral agent
KR20080084477A (en) * 2007-03-16 2008-09-19 원광대학교산학협력단 Compositions containing gall and bark extract with antimicrobial and antiviral activity
KR20090072527A (en) * 2007-12-28 2009-07-02 삼광생명과학 주식회사 A composition containing a gall bladder extract having an antimicrobial activity or a compound separated therefrom as an active ingredient
KR20090072526A (en) * 2007-12-28 2009-07-02 삼광생명과학 주식회사 Veterinary composition containing as an active ingredient, gall extract or antibacterial activity with antibacterial and antiviral activity

Also Published As

Publication number Publication date
KR101317318B1 (en) 2013-10-14
WO2012144754A2 (en) 2012-10-26
KR20120118707A (en) 2012-10-29

Similar Documents

Publication Publication Date Title
WO2012144754A3 (en) Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof
WO2013091775A3 (en) Use of cyclohexanol derivatives as antimicrobial active ingredients
BR112015003376A8 (en) pharmaceutically acceptable compound or salt thereof, pharmaceutical composition and uses of efficient amount of pharmaceutically acceptable compound or salt thereof or pharmaceutical composition
EA201390885A1 (en) AZAINDOLS AS ANTI-VIRAL AGENTS AGAINST THE RESPIRATORY SYNCTIAL VIRUS
WO2010111640A3 (en) Anti-influenza formulations and methods
PH12019550113A1 (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
WO2012065963A3 (en) Antiviral condensed heterocyclic compounds
WO2013179307A3 (en) Stabilized pharmaceutical compositions of saxagliptin
WO2012168430A3 (en) Polypeptides
WO2012037562A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
WO2011049348A3 (en) Antiviral agents obtained from curcuma longa, having inhibitory activities against avian influenza, swine influenza, and novel influenza
PH12019501359A1 (en) Polymorphs
WO2012087037A3 (en) Novel bacteriophage and antibacterial composition comprising the same
EP4327880A3 (en) Solid state form of ribociclib succinate
WO2014121764A3 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
WO2012093234A3 (en) Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus
WO2013109388A3 (en) 1,5-naphthyridine derivatives and melk inhibitors containing the same
WO2011122872A3 (en) Composition comprising coumestrol or a bean extract containing coumestrol
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
WO2013128379A3 (en) Crystalline polymorphic forms of linagliptin
WO2009003719A3 (en) Indane-amine derivatives, their preparation and use as medicaments
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
WO2011149301A3 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12773514

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12773514

Country of ref document: EP

Kind code of ref document: A2